These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 15805070

  • 1. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF, Thorgeirsson SS.
    Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
    [Abstract] [Full Text] [Related]

  • 2. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 3. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 01; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 4. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS.
    Carcinogenesis; 2004 Jun 01; 25(6):901-8. PubMed ID: 14742323
    [Abstract] [Full Text] [Related]

  • 5. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.
    Oncogene; 1996 Aug 15; 13(4):757-65. PubMed ID: 8761297
    [Abstract] [Full Text] [Related]

  • 6. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L, Terradillos O, Calvo L, Costabile B, Cicchini C, Della Rocca C, Lozupone F, Piacentini M, Buendia MA, Tripodi M.
    Oncogene; 2002 Feb 21; 21(9):1335-45. PubMed ID: 11857077
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 21; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 8. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF, Factor VM, Loi R, Thorgeirsson SS.
    Cancer Res; 2001 Mar 01; 61(5):2085-91. PubMed ID: 11280770
    [Abstract] [Full Text] [Related]

  • 9. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM, Sanderson ND, Thorgeirsson SS.
    Cancer Res; 1996 May 01; 56(9):2137-42. PubMed ID: 8616862
    [Abstract] [Full Text] [Related]

  • 10. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM, Jensen MR, Thorgeirsson SS.
    Hepatology; 1997 Dec 01; 26(6):1434-43. PubMed ID: 9397983
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, Arsura M.
    Mol Cancer Res; 2005 Jul 01; 3(7):403-12. PubMed ID: 16046551
    [Abstract] [Full Text] [Related]

  • 12. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H, Sharp R, Hammermeister C, Goodrow T, Bradley MO, Fausto N, Merlino G.
    Cancer Res; 1992 Oct 01; 52(19):5171-7. PubMed ID: 1394122
    [Abstract] [Full Text] [Related]

  • 13. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME, Pierce RH, Fausto N.
    Cancer Res; 2001 Jan 15; 61(2):594-601. PubMed ID: 11212255
    [Abstract] [Full Text] [Related]

  • 14. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
    Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS.
    Cancer Res; 1993 Apr 15; 53(8):1719-23. PubMed ID: 8467484
    [Abstract] [Full Text] [Related]

  • 15. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
    Jakubczak JL, Chisari FV, Merlino G.
    Cancer Res; 1997 Aug 15; 57(16):3606-11. PubMed ID: 9270035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
    Kao CY, Factor VM, Thorgeirsson SS.
    Biochem Biophys Res Commun; 1996 May 06; 222(1):64-70. PubMed ID: 8630075
    [Abstract] [Full Text] [Related]

  • 18. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
    Calvisi DF, Pinna F, Ladu S, Pellegrino R, Muroni MR, Simile MM, Frau M, Tomasi ML, De Miglio MR, Seddaiu MA, Daino L, Sanna V, Feo F, Pascale RM.
    Carcinogenesis; 2008 Aug 06; 29(8):1639-47. PubMed ID: 18579559
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice.
    Tönjes RR, Löhler J, O'Sullivan JF, Kay GF, Schmidt GH, Dalemans W, Pavirani A, Paul D.
    Oncogene; 1995 Feb 16; 10(4):765-8. PubMed ID: 7862454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.